A. Bender

发表

Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides.

D. Gemsa, J. Gong, H. Sprenger, 1990, Journal of immunology.

Influenza A virus infects macrophages and stimulates release of tumor necrosis factor-alpha.

D. Gemsa, J. Gong, H. Sprenger, 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

The potentiating effect of LPS on tumor necrosis factor-alpha production by influenza A virus-infected macrophages.

D. Gemsa, J. Gong, H. Sprenger, 1993, Immunobiology.

Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release.

D. Gemsa, J. Gong, H. Sprenger, 1991, Journal of immunology.

Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity.

D. Gemsa, M. Nain, R. Jäger, 1993, Journal of immunology.

Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response

D. Gemsa, H. Sprenger, M. Nain, 1997, Journal of leukocyte biology.

LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.

D. Jäger, J. Karbach, L. Old, 2007, Cancer immunity.

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.

G. Schuler, M. Heuer, E. Kämpgen, 1999, Journal of immunological methods.

Role of macrophage cytokines in influenza A virus infections.

D. Gemsa, M. Nain, A. Bender, 1993, Immunobiology.

The distinctive features of influenza virus infection of dendritic cells.

G. Kaplan, M. Albert, N. Bhardwaj, 1998, Immunobiology.

Identification of new NY‐ESO‐1 epitopes recognized by CD4+ T cells and presented by HLA‐DQ B1 03011

D. Jäger, J. Karbach, L. Old, 2006, International journal of cancer.

Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma.

J. Karbach, S. Al-Batran, E. Jäger, 2005, Cancer research.

Tumor‐reactive CD8+ T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survival

J. Karbach, N. Altorki, L. Old, 2009, International journal of cancer.

Tumor-reactive CD8 1 T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide V

J. Karbach, N. Altorki, L. Old, 2010 .

Cancer Immunity (19 October 2007) Vol. 7, p. 16

D. Jäger, J. Karbach, L. Old, 2005 .

Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients

J. Karbach, L. Old, E. Jäger, 2010, Clinical Cancer Research.

HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.

D. Jäger, Yao-Tseng Chen, J. Karbach, 2004, Cancer immunity.

HLA-DP 4 expression and immunity to NY-ESO-1 : correlation and characterization of cytotoxic CD 4 + CD 25-CD 8-T cell clones

D. Jäger, Yao-Tseng Chen, J. Karbach, 2004 .

Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses

N. Bhardwaj, M. Feldman, A. Bender, 1995, The Journal of experimental medicine.

Dendritic cells as immunogens for human CTL responses.

R. Steinman, G. Schuler, N. Bhardwaj, 1997, Advances in experimental medicine and biology.

Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector.

E. Hoffmann, G. Hobom, G. Schuler, 2000, Human gene therapy.

The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ.

R. Bucala, J. Chesney, M. Bacher, 1997, Proceedings of the National Academy of Sciences of the United States of America.

LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers

D. Jäger, J. Karbach, S. Gnjatic, 2004, Cancer Cell International.

Monocyte-Derived Dendritic Cells Melanoma Patients by Mature + Inducible in Terminal Stage HLA-A 2 . 1 Peptide-Specific Cytotoxic T Cells Are Mage-3 and Influenza-Matrix

A. Enk, V. Cerundolo, E. Bröcker, 2000 .

Stimulation of human anti-viral CD8+ cytolytic T lymphocytes by dendritic cells.

R. Steinman, N. Bhardwaj, A. Bender, 1995, Advances in experimental medicine and biology.

Tumor-specific killer cells in paraneoplastic cerebellar degeneration

Loise M. Francisco, J. Darnell, R. Darnell, 1998, Nature Medicine.

Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells

G. Schuler, N. Romani, S. Ebner, 2002, The Journal of experimental medicine.

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

A. Enk, R. Steinman, E. Bröcker, 1999, The Journal of experimental medicine.

Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

R. Steinman, N. Bhardwaj, A. Bender, 1994, The Journal of clinical investigation.

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

R. Steinman, G. Schuler, N. Bhardwaj, 1996, Journal of immunological methods.

Characterization of a high molecular weight tumor necrosis factor-alpha mRNA in influenza A virus-infected macrophages.

D. Gemsa, H. Sprenger, M. Nain, 1994, Journal of immunology.

Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells1

A. Enk, V. Cerundolo, E. Bröcker, 2000, The Journal of Immunology.

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients

D. Jäger, J. Karbach, L. Old, 2006, Proceedings of the National Academy of Sciences.

Tumor‐reactive CD8+ T‐cell clones in patients after NY‐ESO‐1 peptide vaccination

J. Karbach, L. Old, S. Gnjatic, 2007, International journal of cancer.

Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients

J. Karbach, L. Old, E. Jäger, 2010, Clinical Cancer Research.